Aurobindo Pharma approves ₹800-crore share buyback

Aurobindo Pharma has approved a share buyback of up to ₹800 crore, according to multiple reports on Monday.

The company has set the buyback price at ₹1,475 per share, while April 17, 2026 has been named as the record date for determining eligible shareholders.

The buyback is being described as a tender offer. NDTV Profit, Business Standard, The Economic Times and Financial Express all reported the same broad terms of the transaction.

Share buybacks typically reduce the number of shares in circulation and can return cash to shareholders. For investors, the key immediate details are the offer size, the fixed price and the record date.

Aurobindo Pharma’s investor website includes a buyback information section, but the direct filing was not surfaced in the search results used for this report.

The announcement comes as the stock market continues to track shareholder-return actions from listed companies, especially when they are paired with a specific repurchase price and a near-term record date.